Skip to main content
Log in

Effects of clofibric and beclobric acid in rat and monkey hepatocyte primary culture: influence on peroxisomal and mitochondrial β-oxidation and the activity of catalase, glutathione S-transferase and glutathione peroxidase

  • Original Investigations
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

The effect of hypolipidaemic compounds on peroxisomal fatty acid β-oxidation and on peroxisome morphology in the liver differs widely between rodent and primate species. We studied the relative importance of peroxisomal and mitochondrial β-oxidation of palmitate in primary cultures of hepatocytes isolated from rat and monkey liver in the absence or presence of clofibric acid or beclobric acid. It was demonstrated that it is possible to differentiate between peroxisomal and mitochondrial β-oxidation activities in intact cells. Overall β-oxidation of palmitate was ca. 30% higher in rat hepatocytes than in monkey liver cells. In both monkey and rat cell cultures the mitochondrial component was over 90% of the total palmitate β-oxidation. In rat hepatocyte culture clofibric acid and beclobric acid caused a 5- to 8-fold stimulation of peroxisomal β-oxidation, while in monkey cells this activity was not significantly increased. However, in cells derived from both species mitochondrial palmitate β-oxidation was increased (rat 2.5-fold; monkey 1.5-fold). These results indicate that the species differences in the increase in peroxisomal fatty acid oxidation are not a result of an inability to metabolize fatty acids in rat liver cell mitochondria. A comparison of the activity of enzymes involved in the detoxification of hydrogen peroxide showed that catalase and glutathione-S-transferase activity is 2.9-fold higher in monkey hepatocytes than in rat liver cells, while glutathione peroxidase activity was 1.6-fold higher in rat cells. When a comparison between both species is made for the ratio of hydrogen peroxide production over catalase activity, it can be concluded that this peroxide will have much smaller possibilities to escape from the peroxisomal compartment in monkey hepatocytes. These findings suggest that species differences in these enzyme activities can contribute to differences in susceptibility for peroxisome proliferator-induced carcinogenicity between rodents and primates.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Adrian RW, Ismail S, Jahn U (1983) Pharmacological studies with beclobrate, a new hypolipidemic agent. Drug Res 33: 1464–1468

    CAS  Google Scholar 

  • Aebi H (1984) Catalase in vitro. Methods Enzymol 105: 121–127

    Article  PubMed  CAS  Google Scholar 

  • Blaauboer BJ, Van Holsteijn CWM, Bleumink R, Mennes WC, Van Pelt FNAM, Yap SH, Van Pelt JF, Van Iersel AAJ, Timmerman A, Schmid BP (1990) The effect of beclobric acid and clofibric acid on peroxisomal β-oxidation and peroxisome proliferation in primary cultures of rat, monkey and human hepatocytes. Biochem Pharmacol 40: 521–528

    Article  PubMed  CAS  Google Scholar 

  • Cayen MN (1980) Metabolic disposition of antihyperlipidemic agents in man and laboratory animals. Drug Metab Rev 11: 291–323

    Article  PubMed  CAS  Google Scholar 

  • Chen RF (1967) Removal of fatty acid from serum albumin by charcoal treatment. J Biol Chem 242: 173–181

    PubMed  CAS  Google Scholar 

  • Elcombe CR, Mitchell AM (1986) Peroxisome proliferation due to di(2-ethylhexyl)-phthalate (DEHP): species differences and possible mechanisms. Environ Health Perspect 70: 211–218

    Article  PubMed  CAS  Google Scholar 

  • Flohé L, Günzler WA (1984) Assays of glutathione peroxidase. Methods Enzymol 105: 114–121

    Article  PubMed  Google Scholar 

  • Foliot A, Touchard D, Mallet L (1986) Inhibition of liver glutathione S-transferase activity in rats by hypolipidemic drugs related or unrelated to clofibrate. Biochem Pharmacol 35: 1685–1690

    Article  PubMed  CAS  Google Scholar 

  • Foxworthy PS, White SL, Hoover DM, Eacho PI (1990) Effect of ciprofibrate bezafribrate, and LY171883 on peroxisomal β-oxidation in cultured rat, dog, and rhesus monkey hepatocytes. Toxicol Appl Pharmacol 104: 386–394

    Article  PubMed  CAS  Google Scholar 

  • Green S (1992) Receptor-mediated mechanisms of peroxisome proliferators. Biochem Pharmacol 43: 393–401

    Article  PubMed  CAS  Google Scholar 

  • Grundy SM, Ahrens EH, Salen G, Schreibman PH, Nestel PJ (1972) Mechanisms of action of clofibrate on cholesterol metabolism in patients with hyperlipidemia. J Lipid Res 13: 531–551

    PubMed  CAS  Google Scholar 

  • Habig WH, Pabst MJ, Jakoby WB (1974) Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249: 7130–7139

    PubMed  CAS  Google Scholar 

  • Hanefeld M, Kemmer C, Kadner E (1983) Relationship between morphological changes and lipid-lowering action of p-chlorphenoxyisobutyric acid (CPIB) on hepatic mitochondria and peroxisomes in man. Atherosclerosis 46: 239–246

    Article  PubMed  CAS  Google Scholar 

  • Hanson RW, Ballard FJ (1968) Citrate, pyruvate and lactate contaminants of commercial serum albumin. J Lipid Res 9: 667–668

    PubMed  CAS  Google Scholar 

  • Hawkins JM, Jones WE, Bonner FW, Gibson GG (1987) The effect of peroxisome proliferators on microsomal, peroxisomal, and mitochondrial enzyme activities in the liver and kidney. Drug Metab Rev 18: 441–515

    Article  PubMed  CAS  Google Scholar 

  • Issemann I, Green S (1990) Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347: 645–650

    Article  PubMed  CAS  Google Scholar 

  • Kasai H, Okada Y, Nishimura S, Rao MS, Reddy JK (1989) Formation of 8-hydroxy-deoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator. Cancer Res 49: 2603–2605

    PubMed  CAS  Google Scholar 

  • Levander OA (1992) Selenium and sulfur in antioxidant protective systems: relationships with vitamin E and malaria. Proc Soc Exp Biol Med 200: 255–259

    PubMed  CAS  Google Scholar 

  • Mannaerts GP, Debeer LJ, Thomas F, De Schepper PJ (1979) Mitochondrial and peroxisomal fatty acid oxidation in liver homogenates and isolated hepatocytes from control and clofibrate treated rats. J Biol Chem 254: 4585–4595

    PubMed  CAS  Google Scholar 

  • Mannervik B (1987) Glutathione transferase. In: Benford D, Bridges JW, Gibson GG (eds) Drug metabolism from molecules to man. Taylor and Francis, London, pp 30–39

    Google Scholar 

  • Marsman DS, Cattley RC, Conway JG, Popp JA (1988) Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats. Cancer Res 48: 6739–6744

    PubMed  CAS  Google Scholar 

  • Mennes WC, Van Holsteijn CWM, Timmerman A, Noordhoek J, Blaauboer BJ (1991) Biotransformation of scoparone used to monitor changes in cytochrome P450 activities in primary hepatocyte cultures derived from rats, hamsters and monkeys. Biochem Pharmacol 41: 1203–1208

    Article  PubMed  CAS  Google Scholar 

  • Mitchell AM, Bridges JW, Elcombe CR (1984) Factors influencing peroxisome proliferation in cultured rat hepatocytes. Arch Toxicol 55: 239–246

    Article  PubMed  CAS  Google Scholar 

  • Oliver MF (1978) Cholesterol, coronaries, clofibrate and death. N Engl J Med 299: 1360–1362

    Article  PubMed  CAS  Google Scholar 

  • Orton TC, Adams HK, Bentley M, Holloway B, Tucker MJ (1984) Clobuzarit: species differences in the morphological and biochemical response of the liver following chronic administration. Toxicol Appl Pharmacol 73: 138–151

    Article  PubMed  CAS  Google Scholar 

  • Paine AJ, Williams LJ, Legg RF (1979) Determinants of cytochrome P-450 in liver cell cultures. In: Preisig R, Bircher J (eds) The liver: quantitative aspects of structure and function. Editio Cantor, Aulendorf, Vol. 3, pp 99–109

    Google Scholar 

  • Rao MS, Reddy JK (1989) The relevance of peroxisome proliferation and cell proliferation in peroxisome proliferator-induced hepatocarcinogenesis. Drug Metab Rev 21: 103–110

    Article  PubMed  CAS  Google Scholar 

  • Rao MS, Lalwani ND, Watanabe TK, Reddy JK (1984) Inhibitory effect of antioxidants ethoxyquin and 2(3)-tert-butyl-4-hydroxyanisole on hepatic tumorigenesis in rats fed ciprofibrate, a peroxisome proliferator. Cancer Res 44: 1072–1076

    PubMed  CAS  Google Scholar 

  • Reddy JK, Lalwani ND (1983) Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. CRC Crit Rev Toxicol 12: 1–58

    Article  CAS  Google Scholar 

  • Reddy JK, Azarnoff DL, Hignite CE (1980) Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature 283: 397–398

    Article  PubMed  CAS  Google Scholar 

  • Reddy JK, Lalwani ND, Quereshi SA, Reddy MK, Moehle CM (1984) Induction of hepatic peroxisome proliferation in non-rodent species, including primates. Am J Pathol 114: 171–183

    PubMed  CAS  Google Scholar 

  • Redegeld FAM, Moison RMW, Koster AS, Noordhoek J (1992) Depletion of ATP but not of GSH affects viability of rat hepatocytes. Eur J Pharmacol 228: 229–236

    PubMed  CAS  Google Scholar 

  • Roth VW, Proxi A, Ifflaender U (1985) Untersuchungen zur Metabolisierung von Beclobrat bei Ratte und Mensch. Arzneimittelforschung 35: 244–251

    PubMed  CAS  Google Scholar 

  • Rutten AAJJL, Falke HE, Catsburg JF, Topp R, Blaauboer BJ, Van Holsteijn I, Doorn L, Van Leeuwen FXR (1987) Interlaboratory comparison of total cytochrome P450 and protein determinations in rat liver microsomes. Arch Toxicol 61: 27–33

    Article  PubMed  CAS  Google Scholar 

  • Seglen PO (1976) Preparation of isolated liver cells. Methods Cell Biol 13: 29–83

    Article  PubMed  CAS  Google Scholar 

  • Sharma R, Lake BG, Foster J, Gibson GG (1988) Microsomal cytochrome P-452 induction and peroxisome proliferation by hypolipidaemic agents in rat liver. A mechanistic inter-relationship. Biochem Pharmacol 37: 1193–1201

    Article  PubMed  CAS  Google Scholar 

  • Tomaszewski KE, Agarwal DK, Melnick RL (1986) In vitro steady-state levels of hydrogen peroxide after exposure of male F344 rats and female B6C3F1 mice to hepatic peroxisome proliferators. Carcinogenesis 7: 1871–1876

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mennes, W.C., Wortelboer, H.M., Hassing, G.A.M. et al. Effects of clofibric and beclobric acid in rat and monkey hepatocyte primary culture: influence on peroxisomal and mitochondrial β-oxidation and the activity of catalase, glutathione S-transferase and glutathione peroxidase. Arch Toxicol 68, 506–511 (1994). https://doi.org/10.1007/s002040050103

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002040050103

Key words

Navigation